Vaxxinity

Dallas, United States

Vaxxinity is a biotechnology company that enables the innovation of synthetic peptide vaccines to prevent or treat infectious diseases.

$9.3M raised

Apr 2022

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vaxxinity raised?

Vaxxinity has raised $9.3M in total funding. The most recent round was Grant. The last funding was announced in April 2022.

Who are Vaxxinity's investors?

Vaxxinity's investors include Coalition for Epidemic Preparedness Innovations, White Buffalo Capital.

Where is Vaxxinity headquartered?

Vaxxinity is headquartered in Dallas, United States.

What does Vaxxinity do?

Vaxxinity is a biotechnology company that enables the innovation of synthetic peptide vaccines to prevent or treat infectious diseases.

What stage is Vaxxinity at?

Vaxxinity is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 6, 2022.

MLA

"Vaxxinity — Funding & Investors." VCBacked, April 6, 2022, https://www.vcbacked.co/company/vaxxinity. Accessed July 2, 2026.

APA

VCBacked. (2022). Vaxxinity — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vaxxinity

Wikipedia (cite web)

{{cite web |title=Vaxxinity — Funding & Investors |url=https://www.vcbacked.co/company/vaxxinity |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 6, 2022.